MSK Doctors (03300010048), a private, London-based practice that specialises in treating musculoskeletal disorders, has released a new guide comparing Arthrosamid with other knee injections.
-- The recently published guide compares the long-term efficacy of Arthrosamid hydrogel knee injections to that of other non-invasive methods of managing knee osteoarthritis, particularly stem cell therapy. Patients interested in delaying knee surgery for as long as possible are encouraged to read the guide to learn about their treatment options.
For more information, please visit https://mskdoctors.com/doctors/thula-chelvan/articles/arthrosamid-vs-stem-cell-therapy-for-knee-pain-effectiveness-side-effects-cost
Knee osteoarthritis is one of the most common types of arthritis and the fastest-growing cause of disability worldwide, according to a study in the Osteoarthritis and Cartilage journal. It is characterized by the degeneration of the shock-absorbing cartilage in the knee, resulting in inflammation of the synovial tissue within the joint. Because there have been no therapies that can delay the progression of the disease, most treatments focus on pain relief and symptom management; however, stem cell therapy and Arthrosamid injections have recently emerged as potential long-term alternatives to both surgery and other types of injections.
MSK Doctors’ guide explains that for stem cell therapy, stem cells are injected into the knee, where they transform into cells that can potentially repair damaged cartilage, addressing the root cause of osteoarthritis. Studies suggest that this treatment can reduce pain and improve knee function, but because its mechanisms are reliant on the body’s natural healing processes, results may take longer; the stem cells themselves also carry the risk of growing into the wrong cell types, hindering regeneration.
On the other hand, Arthrosamid involves the injection of a synthetic hydrogel into the synovial fluid, where it attaches to the joint and acts as cushioning. Because the gel is not absorbable, it will remain integrated with the synovial tissue, with clinical trials showing improved biomechanical function and pain reduction that can last for at least two years. Moreover, Arthrosamid requires only one injection, making it more cost-effective over the long term.
When considering treatment options, MSK Doctors’ guide says that patients with late-stage osteoarthritis may benefit more from stem cell therapy due to its regenerative potential, while those with moderate osteoarthritis may find the lasting relief offered by Arthrosamid to be more advantageous. Individuals suffering from the condition are ultimately encouraged to consult their physician to discuss which procedure is best for their situation.
Interested parties can learn more by visiting https://mskdoctors.com/
Contact Info:
Name: Bethan Lee
Email: Send Email
Organization: MSK Doctors
Address: MSK House London Road Silk Willoughby, Sleaford, Lincolnshire, Sleaford, England NG34 8NY, United Kingdom
Website: https://www.mskdoctors.com
Source: PressCable
Release ID: 89158793
Should any errors, concerns, or inconsistencies arise from the content provided in this press release that require attention or if a press release needs to be taken down, we kindly request that you immediately contact us at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will be at your disposal for timely assistance within 8 hours – taking necessary measures to rectify identified issues or providing guidance on the removal process. We prioritize delivering accurate and reliable information.